-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Omos7IH2tiqYc+yDFtGNDmeYfp9UVwp77J1dVXa2Ytyig2B5m7BAEeOvul1CLxxB 2oB6Y9yD0YUTGA687Phk7w== 0000937889-04-000002.txt : 20040212 0000937889-04-000002.hdr.sgml : 20040212 20040212194959 ACCESSION NUMBER: 0000937889-04-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040210 FILED AS OF DATE: 20040212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RENOVIS INC CENTRAL INDEX KEY: 0001118361 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943353740 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO CORPORATE DR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-1400 MAIL ADDRESS: STREET 1: TWO CORPORATE DR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VENROCK ASSOCIATES CENTRAL INDEX KEY: 0000937889 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50564 FILM NUMBER: 04593915 BUSINESS ADDRESS: STREET 1: ROOM 5508 STREET 2: 30 ROCKEFELLER PLAZA CITY: NEW YORK STATE: NY ZIP: 10112 BUSINESS PHONE: 2126495600 MAIL ADDRESS: STREET 1: ROOM 5508 STREET 2: 30 ROCKEFELLER PLAZA CITY: NEW YORK STATE: NY ZIP: 10112 4 1 edgar.xml PRIMARY DOCUMENT X0201 4 2004-02-10 1 0001118361 RENOVIS INC RNVS 0000937889 VENROCK ASSOCIATES 30 ROCKEFELLER PLAZA, ROOM 5508 NEW YORK NY 10112 0 0 1 0 Common Stock 816 D Common Stock 2004-02-10 4 C 0 112332 A 113148 D Common Stock 2004-02-10 4 C 0 91573 A 204721 D Common Stock 2004-02-10 4 C 0 120000 A 324721 D Series B Preferred Stock 2004-02-10 4 C 0 505494 D Common Stock 112332 0 D Series C Preferred Stock 2004-02-10 4 C 0 412079 D Common Stock 91573 0 D Series E Preferred Stock 2004-02-10 4 C 0 540000 D Common Stock 120000 0 D Reflects the 1-for-4.5 reverse stock split effected prior to the effectiveness of the Issuer's initial public offering. A portion of these shares is subject to a right of repurchase held by the Issuer. Reflects the 1-for-4.5 reverse stock split effected prior to the effectiveness of the Issuer's initial public offering. The shares of each Series of Preferred Stock were convertible into the number of shares of Common Stock indicated, and upon the closing of the Issuer's initial public offering of Common Stock, all such shares of Preferred Stock were automatically converted into the number of shares of Common Stock indicated. The conversion ratio for the Series B Preferred Stock is obtained by dividing the Original Price ($1.80) by the Conversion Price ($1.638). (e.g., One share of Series B Preferred Stock is convertible into approximately 1.099 shares of Common Stock.) Gives effect to the conversion of the Series B Preferred Stock into Common Stock but does not reflect the 1-for-4.5 reverse stock split effected prior to the effectiveness of the Issuer's inital public offering. Not applicable. The conversion ratio for the Series C Preferred Stock is obtained by dividing the Original Price ($2.50) by the Conversion Price ($2.053). (e.g., One share of Series C Preferred Stock is convertible into approximately 1.218 shares of Common Stock.) Gives effect to the conversion of the Series C Preferred Stock into Common Stock but does not reflect the 1-for-4.5 reverse stock split effected prior to the effectiveness of the Issuer's initial public offering. Converts on a 1-for-1 basis into Common Stock. Anthony B. Evnin, General Partner 2004-02-12 -----END PRIVACY-ENHANCED MESSAGE-----